Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Screening Methods for Treatment of Meibomian Gland Dysfunction

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2/PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Meibomian gland dysfunction~* Dry Eye symptoms~Exclusion Criteria:~* Ocular surgery, ocular injury or ocular Herpes infection within past 3 months~* Active ocular infection~* Active ocular inflammation or recurrent inflammation within past 3 months~* Moderate to severe allergic conjunctivitis~* Severe eyelid inflammation~* Eyelid abnormalities that affect lid function~* Ocular surface abnormalities that may compromise corneal integrity~* Systemic disease conditions or medications that cause dry eye~* Use of other treatments for meibomian gland dysfunction or dry eye~* Pregnant or nursing women~* Participation in another ophthalmic clinical trial within past 30 days

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- LipiFlow Treatment (Type: EXPERIMENTAL): Treatment with LipiFlow device

Based on this trial design, predict the completion outcome and termination type (if applicable).